Literature DB >> 8725391

Angiotensin receptors and their therapeutic implications.

K K Griendling1, B Lassègue, R W Alexander.   

Abstract

Angiotensin II is a multifunctional hormone that exerts its effects by interacting will cell surface receptors. Two major subtypes of receptors (AT1 and AT2) have been distinguished by pharmacological and molecular biological techniques. AT1 receptors have been further subdivided into AT1A and AT1B receptors. Several other isoforms have been found, notably in nonmammalian systems, but further information is necessary before definitive classification can be made. AT1 receptors mediate most known functions of angiotensin II, while AT2 receptors may be important developmentally. The molecular, structural, and biochemical characteristics of these receptors have been described, as well as the factors that regulate their expression. This receptor system has been implicated in several cardiovascular diseases, including hypertension, restenosis after angioplasty, cardiac hypertrophy, heart failure, myocardial infarction, and ventricular remodeling. Structural analysis of AT receptors may provide the basis for the development of new therapeutic agents with enhanced specificity for the treatment of these diseases.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8725391     DOI: 10.1146/annurev.pa.36.040196.001433

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  43 in total

1.  Intracellular Angiotensin II and cell growth of vascular smooth muscle cells.

Authors:  C M Filipeanu; R H Henning; D de Zeeuw; A Nelemans
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

2.  Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway.

Authors:  C Nataraj; M I Oliverio; R B Mannon; P J Mannon; L P Audoly; C S Amuchastegui; P Ruiz; O Smithies; T M Coffman
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

Review 3.  Novel actions of angiotensin II via its renal type-2 (AT(2)) receptor.

Authors:  R M Carey; Z Q Wang; H M Siragy
Journal:  Curr Hypertens Rep       Date:  1999 Apr-May       Impact factor: 5.369

4.  Catalog of 178 variations in the Japanese population among eight human genes encoding G protein-coupled receptors (GPCRs).

Authors:  Susumu Saito; Aritoshi Iida; Akihiro Sekine; Saori Kawauchi; Shoko Higuchi; Chie Ogawa; Yusuke Nakamura
Journal:  J Hum Genet       Date:  2003-08-30       Impact factor: 3.172

5.  Use of angiotensin receptor antagonists in patients with ACE inhibitor induced angioedema.

Authors:  Sabine A Fuchs; Ronald H B Meyboom; Eugène P van Puijenbroek; Henk-Jan Guchelaar
Journal:  Pharm World Sci       Date:  2004-08

Review 6.  Evidence for a functional intracellular angiotensin system in the proximal tubule of the kidney.

Authors:  Brianne Ellis; Xiao C Li; Elisa Miguel-Qin; Victor Gu; Jia L Zhuo
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-12-14       Impact factor: 3.619

Review 7.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

8.  Localization of angiotensin-II type 1(AT1) receptors on buffalo spermatozoa: AT1 receptor activation during capacitation triggers rise in cyclic AMP and calcium.

Authors:  Sivaram Vedantam; Rita Rani; Monica Garg; Suresh K Atreja
Journal:  Mol Biol Rep       Date:  2014-01-17       Impact factor: 2.316

Review 9.  Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities.

Authors:  Juan M Saavedra
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

10.  Angiotensin II induces a region-specific hyperplasia of the ascending aorta through regulation of inhibitor of differentiation 3.

Authors:  A Phillip Owens; Venkateswaran Subramanian; Jessica J Moorleghen; Zhenheng Guo; Coleen A McNamara; Lisa A Cassis; Alan Daugherty
Journal:  Circ Res       Date:  2009-12-17       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.